Essity AB, a global leader in hygiene and health products, presents a strong investment case as a consumer compounder. The company has been executing a margin improvement program, focusing on cost savings and premium product mix, which is expected to drive earnings growth. With a robust balance sheet and consistent free cash flow, Essity is well-positioned to navigate inflationary pressures and deliver shareholder returns through dividends and buybacks.
Investment Thesis
Essity’s transformation towards higher-margin professional hygiene and health categories, combined with operational efficiencies, should lead to sustainable mid-single-digit organic growth and expanding margins. The company’s strong brand portfolio (TENA, Tork, Libero) and market leadership provide pricing power and resilience.
12-Month Catalysts
- Margin recovery from cost-saving initiatives and raw material cost moderation.
- Innovation in sustainable products (e.g., plant-based materials) driving market share gains.
- Potential divestiture of non-core assets to unlock value.
Key Risks
- Raw material price volatility (pulp, oil-based inputs).
- Intense competition from private labels and peers.
Valuation
Trading at ~15x forward P/E with a dividend yield of ~3.5%, Essity offers a reasonable valuation relative to its defensive growth profile and margin improvement trajectory.
Balance Sheet
Essity maintains a strong investment-grade balance sheet with net debt/EBITDA below 2x, ample liquidity, and consistent free cash flow generation.
Disclaimer: This is not financial advice. Please conduct your own research before investing.